Skip to main content

Table 3 PAR (95%CI) for metabolic syndrome components according to the criteria, by sex

From: Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions

 

NCEP-ATPIII

IDF

AHA/NHLBI

Men

   

Abnormal waist circumference *

33.1 (23.1 - 43.1)

100.0

80.6 (73.3-87.8)

HDL-Cholesterol <40 or <50 mg/dlǂ

65.2 (52.9 - 77.5)

37.9 (25.2 - 50.6)

50.2 (39.6-60.7)

Triglycerides ≥150 mg/dl

88.8 (80.9-96.7)

74.3 (64.7 - 83.9)

79.4 (71.7-87.2)

Fasting glucose ≥100 mg/d

42.6 (31.2 - 53.9)

33.5 (23.9 - 43.2)

37.1 (28.5-45.7)

Blood pressure ≥130/85 mmHg

68.0 (56.5 - 79.6)

55.4 (44.2 - 66.7)

59.2 (49.5-68.9)

Women

   

Abnormal waist circumference *

80.4 (72.1-88.7)

100.0

89.8 (82.9-96.7)

HDL-Cholesterol <40 or <50 mg/dlǂ

66.7 (55.8-77.6)

60.7 (50.1-71.2)

63.0 (53.1-72.9)

Triglycerides ≥150 mg/dl

64.1 (53.5-74.7)

61.2 (51.7-70.8)

62.2 (53.0-71.4)

Fasting glucose ≥100 mg/d

44.5 (34.5 - 54.4)

38.9 (30.0-47.9)

40.8 (32.3-49.4)

Blood pressure ≥130/85 mmHg

62.6 (52.5-72.8)

57.4 (47.9-66.9)

58.8 (49.7-67.8)

  1. PAR: Population Attributable Risk adjusted for age, skin color, and HAART use.
  2. * NCEP-ATPIII (National Cholesterol Education Program-Adult Treatment Panel III) ≥ 102 cm in men, ≥ 88 cm in women; IDF (International Diabetes Federation) and AHA/NHLBI (American Heart Association/National Heart, Lung and Blood Institute) definition ≥ 90 cm in men, ≥ 80 cm in women according the thresholds for South Americans.